Prophylactic anticonvulsants after subarachnoid hemorrhage

World Neurosurgery

Volumn 75, Issue 2, 2011, Pages 214-

  Usami, Kenichi ^a   Saito, Nobuhito ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Levetiracetam; Phenytoin; Seizures; Subarachnoid hemorrhage

Indexed keywords

ETIRACETAM; PHENYTOIN;

COGNITIVE DEFECT; CONTROLLED STUDY; HUMAN; PROPHYLAXIS; QUALITY OF LIFE; SEIZURE; SHORT SURVEY; SUBARACHNOID HEMORRHAGE;

EID: 79953867906     PISSN: 18788750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.wneu.2010.09.035     Document Type: Article

References (4)

1. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE Jr, Harbaugh RE, Patel AB, Rosenwasser RH: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994-1025, 2009.
2. Claassen J, Peery S, Kreiter KT, Hirsch LJ, Du EY, Connolly ES, Mayer SA: Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 60:208-214, 2003. (Pubitemid 36152010)
3. Lin CL, Dumont AS, Lieu AS, Yen CP, Hwang SL, Kwan AL, Kassell NF, Howng SL: Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg 99:978-985, 2003. (Pubitemid 44717392)
4. Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF: Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 36:583-587, 2005. (Pubitemid 40352567)